期刊文献+

胸腺瘤合并重症肌无力的外科治疗 被引量:2

Surgical treatment of thymoma associated with myasthenia gravis
原文传递
导出
摘要 目的观察胸腺瘤合并重症肌无力(MG)的外科治疗效果。方法外科治疗21例胸腺瘤合并重症肌无力患者,按Osserman标准分为Ⅰ型1例、Ⅱa型7例、Ⅱb型10例、Ⅲ型3例。结果术后5例发生危象,均采用气管切开及辅助呼吸。随访半年至6年,平均36个月,5年内死亡4例。结论胸腺瘤合并重症肌无力者较常见,宜采用手术、放疗、化疗等综合治疗。围手术期应合理应用抗胆碱酯酶药,积极防治并发症及危象。 Objective To investigate the efficacy of surgical treatment for 21 patients with thymoma associated with myasthenia gravis(MG).Methods 21 patients with thymoma associated with MG were treated surgically from 1990 to 2003.According to the Osserman staging system,stage Ⅰ was in 1 patient,stage Ⅱ in 17 patients,stage Ⅲ in 3 patients.Results The important postoperative complications were myasthenia crisis in 5 patients.With follow-up was from 6 months to 6 years,with an average of 36 months,4 cases died in 5 years.Conclusions Thymectomy is the first choice treatment of thymoma associated with MG.The incidence of postoperative crisis is very high.Prompt tracheotomy and assisted respiratory support are very important in the management of crisis.
出处 《中国基层医药》 CAS 2005年第2期174-175,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 胸腺瘤 重症肌无力 外科治疗 危象 常见 辅助呼吸 防治并发症 合并 标准分 结论 Thymoma Myasthenia gravis Surgical treatment
  • 相关文献

参考文献8

二级参考文献17

  • 1张志庸,徐乐天.重症肌无力单纯胸腺切除疗效分析[J].中华胸心血管外科杂志,1993,9(2):108-110. 被引量:15
  • 2吕传真.骨骼肌疾病[M].上海:上海科技出版社,1987.138.
  • 3费立夫 李翠艳 等.8例重症肌无力合并甲状腺功能亢进外科治疗体会[J].中华胸心血管外科杂志,2000,16(1):8-8.
  • 4程静林,李静,于明达,王春亭,任战军.静脉麻醉加硬膜外阻滞在食管癌手术中的应用[J].中华麻醉学杂志,1997,17(1):48-49. 被引量:33
  • 5张志庸,中华胸心血管外科杂志,1993年,9卷,108页
  • 6吕传真,骨骼肌疾病,1987年,238页
  • 7Nieto PI, Roblel PPJ, Pajulo CM, et al. Prognostic factors for myathenia gravis treated by thymectomy: review of 61 cases. Ann Thorac Surg,1999,67:1568-1571.
  • 8Papatestas AE, Genkins G, Kornfeld P, et al. Effects of thymectomy in myathenia gravis. Ann Surg, 1987,206:79-88.
  • 9Paletto AE, Maggi G. Thymectomy in the treatment of myathenia gravis: result in 320 patients. Int Surg, 1982,67:13-16.
  • 10Masaoka A, Yamakawa Y, Niwa H, et al. Thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg,1996,64:853-859.

共引文献243

同被引文献13

  • 1邵明海,陈仕林,卢洪胜,周涛,王碧云.胸腺瘤WHO组织学分型、Masaoka临床分期和预后的关系[J].实用肿瘤学杂志,2007,21(2):128-130. 被引量:10
  • 2邱琳,朱宪明.胸腺瘤与胸腺瘤合并重症肌无力临床分析[J].中国医药,2007,2(8):480-481. 被引量:5
  • 3Suster S,Moran CA.Thymoma classification:current status and future trends.Am J Clin Pathol,2006,125(4):542-554.
  • 4Duwe BV,Stermam DH,Musani AI.Tumors of the mediastinum.Chest,2005,128(4):2893-2909.
  • 5Le Péchoux C,Mahé M,Bretel JJ,et al.Thymic tumors.Cancer Radiother,2005,9(6-7):351-357.
  • 6Cooper JD.Current therapy for thymoma.Chest,1993,103(4 Sup-pi):334S-336S.
  • 7Rea F,Marulli G,Girardi R,et al.Long-term survival and prog-nostic factors in thymic epithelial tumours.Eur J Cardiothorac Surg,2004,26(2):412-418.
  • 8Ichimura H,Usui S,Okazaki H,et al.Excision after chemoradio-therapy of invasive thymoma extending into the right atrium:report of a case.Surg Today.2006,36(6)-534-537.
  • 9Wright CD,Kessler KA.Surgical treatment of thymic tumors.Se-min Thorac Cardiovasc Surg,2005,17(1):20-26.
  • 10Eng TY,Thomas CR Jr.Radiation therapy in the management of thymic tumors.Semin Thorac Cardiovasc Surg,2005,17 (1):32-40.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部